The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda

African Health Sciences

Volumn 9, Issue 1, 2009, Pages 40-45

  Kirimuhuzya, Claude ^a   Waako, Paul ^a   Joloba, Moses ^a   Odyek, Olwa ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

Anti mycobacterial; In vitro activity; Lantana camara; Medicinal plant; Mycobacterium tuberculosis; Rifampicin

Indexed keywords

LANTANA CAMARA EXTRACT; RIFAMPICIN; CHLOROFORM; METHANOL; PLANT EXTRACT; TUBERCULOSTATIC AGENT;

AGAR DIFFUSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; LANTANA CAMARA; MALE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SYMPTOM; TUBERCULOSIS; UGANDA; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; HUMAN; LANTANA; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PHYTOTHERAPY; PLANT LEAF; RESPIRATORY TRACT DISEASES; TRADITIONAL MEDICINE;

ANTITUBERCULAR AGENTS; CHLOROFORM; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LANTANA; MEDICINE, TRADITIONAL; METHANOL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RESPIRATORY TRACT DISEASES; TUBERCULOSIS; UGANDA;

EID: 77949409047     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. st March 2005].
2. Centres for Disease Control (2005). Worldwide emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs. Trends in Tuberculosis - United States, MMWR; 55(10): TK-TK.
3. Navin TR, Mc Nab SJ, Crawford JT (2002). The continued threat to tuberculosis. Emerg Infec Dis. (8), 1187.
4. Sanjay MJ (2004). Natural Products: An important source for Anti-tubercular Drugs. CRISP; 5 (1).
5. Dye C, Scheele S, Dolin P, Pathenia V, Raviglione MC (1999). Global Burden of TB: estimated incidence, prevalence and mortality by country. JAMA. 282: 677-686 .
6. Mubiru N, Ogwal-Okeng, J.W., Amai, C., Kakooko, A.B., Mutyaba, J.B. et al.(1995). Ethnomedicine in Uganda Series. National Chemotherapeutics Research Laboratories.
7. Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J (2003). Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res. 17 (8): 903-8.
8. Ameen OM, Fatope OM, Usman LA, Adebayo SA (2005). Bioactive metabolites in improved cow pea seeds. African Journal of Biotechnology, 4 (6): 513-516.
9. Betancur-Galvis LA, Morales GE, Forero JE, Roldan J (2002). Cytotoxic and Antiviral Activities of Colombian Medicinal Plant Extracts of the Euphorbia genus. Mem. Inst. Oswaldo Cruz. 97(4): 541-546
10. Pereira M, Tripathy S, Inamdar V, Ramesh K, Bhavsar M, Date M et al. (2005). Drug resistance patterns of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res, 121 (4): 235-239.
11. McCarter YS and Robinson R. (1994). Detection of acid-fast bacilli in concentrated primary specimen smears stained with rhodamine -auramine at room temperature and at 37°C. Journal of Clinical Microbiology. 32 (10):
12. Kent BD, Kubica GP (1985). Public health mycobacteriology guide for level III Laboratory. Atlanta.
13. Lee, C.N., Heifets, L.B. (1987). Determination of minimum inhibitory concentration of anti-tuberculous drugs by radiometric and conventional methods. Am Rev Respir Dis. 136 (2): 349-352.
14. nd Edition 1-11; 153-190.Scientific Book Agency, Calcutta.